AAAAAA
Results:
1-8
|
Results: 8
Authors:
Woodburn, KW
Rodriguez, S
Robbins, RC
Kessel, D
Yamaguchi, A
Citation: Kw. Woodburn et al., Photodynamic therapy using motexafin lutetium in allograft coronary arterydisease, J PORPHYR P, 5(2), 2001, pp. 130
Authors:
Chen, ZP
Woodburn, KW
Shi, C
Adelman, DC
Rogers, C
Simon, DI
Citation: Zp. Chen et al., Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells, ART THROM V, 21(5), 2001, pp. 759-764
Authors:
Miller, RA
Woodburn, KW
Fan, Q
Lee, I
Miles, D
Duran, G
Sikic, B
Magda, D
Citation: Ra. Miller et al., Motexafin gadolinium: A redox active drug that enhances the efficacy of bleomycin and doxorubicin, CLIN CANC R, 7(10), 2001, pp. 3215-3221
Authors:
Yamaguchi, A
Woodburn, KW
Hayase, M
Hoyt, G
Robbins, RC
Citation: A. Yamaguchi et al., Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimentalgraft coronary artery disease, TRANSPLANT, 71(11), 2001, pp. 1526-1532
Authors:
Woodburn, KW
Citation: Kw. Woodburn, Intracellular localization of the radiation enhancer motexafin gadolinium using interferometric Fourier fluorescence microscopy, J PHARM EXP, 297(3), 2001, pp. 888-894
Authors:
Rockson, SG
Lorenz, DP
Cheong, WF
Woodburn, KW
Citation: Sg. Rockson et al., Photoangioplasty - An emerging clinical cardiovascular role for photodynamic therapy, CIRCULATION, 102(5), 2000, pp. 591-596
Authors:
Yamaguchi, A
Woodburn, KW
Hayase, M
Robbins, RC
Citation: A. Yamaguchi et al., Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model, CIRCULATION, 102(19), 2000, pp. 275-280
Authors:
Blumenkranz, MS
Woodburn, KW
Qing, F
Verdooner, S
Kessel, D
Miller, R
Citation: Ms. Blumenkranz et al., Lutetium texaphyrin (lu-tex): A potential new agent for ocular fundus angiography and photodynamic therapy, AM J OPHTH, 129(3), 2000, pp. 353-362
Risultati:
1-8
|